NCT07167719 Resilience in Reentry: Cognitive-Behavioral Resilience Training for Parolees With Adjustment Challenges
| NCT ID | NCT07167719 |
| Status | Recruiting |
| Phase | — |
| Sponsor | University of California, Irvine |
| Condition | Adjustment |
| Study Type | INTERVENTIONAL |
| Enrollment | 60 participants |
| Start Date | 2026-01-27 |
| Primary Completion | 2026-09 |
Eligibility & Interventions
Eligibility Fast-Check
Enter your details for a quick preliminary check. This does not replace medical advice.
What to Expect as a Participant
You will actively receive the study intervention — which may be a drug, biologic, device, or procedure.
This trial targets 60 participants in total. It began in 2026-01-27 with a primary completion date of 2026-09.
⚠ This information is for research awareness only. Always consult your physician before joining any clinical trial. Participation is voluntary and you may withdraw at any time.
Brief Summary
This pilot study assesses the feasibility and acceptability of delivering a brief Cognitive-Behavioral Resiliency treatment to a population of recently released parolees. This study will also give a preliminary indication if the treatment is associated with reliable improvements in adjustment symptoms and well-being for parolees.
Eligibility Criteria
Inclusion Criteria: * 18 years or older * Speaks English * Been on parole for two years or less. * Score of 8.5 or higher (range 4 to 16) on the Adjustment Disorder New Module 4 (ADNM-4) screening tool (Ben-Ezra, et al., 2018). Exclusion Criteria: None
Contact & Investigator
Emily Owens
STUDY DIRECTOR
University of California, Irvine
Frequently Asked Questions
Who can join the NCT07167719 clinical trial?
This trial is open to participants of all sexes, aged 18 Years or older, studying Adjustment. Full inclusion and exclusion criteria are listed in the Eligibility Criteria section. Always confirm your eligibility with the research team before applying.
Is NCT07167719 currently recruiting?
Yes, NCT07167719 is actively recruiting participants. Contact the research team at jdecaro@uci.edu for enrollment information.
Where is the NCT07167719 trial being conducted?
This trial is being conducted at Los Angeles, United States.
Who is sponsoring the NCT07167719 clinical trial?
NCT07167719 is sponsored by University of California, Irvine. The principal investigator is Emily Owens at University of California, Irvine. The trial plans to enroll 60 participants.